BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9931637)

  • 1. [Primary liver and bile duct tumors: approach to conservative therapy].
    Henne-Bruns D; Marks HG
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():343-7. PubMed ID: 9931637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic interventional radiology procedures in hepatocellular carcinoma].
    Huppert PE; Viebahn R; Duda SH; Lauchart W
    Zentralbl Chir; 1994; 119(11):787-93. PubMed ID: 7531377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
    Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
    Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nonsurgical therapy methods in hepatocellular carcinoma].
    Wettstein M; Häussinger D
    Praxis (Bern 1994); 2001 Jan; 90(1-2):15-20. PubMed ID: 11206095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatocellular carcinoma: percutaneous ethanol injection/transarterial chemoembolization/radiofrequency thermoablation].
    Allgaier HP; Rossi S; Deibert P; Zuber I; Hering M; Blum HE
    Praxis (Bern 1994); 2000 Jun; 89(24):1056-60. PubMed ID: 10902462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoembolization and bland embolization: a critical appraisal.
    Befeler AS
    Clin Liver Dis; 2005 May; 9(2):287-300, vii. PubMed ID: 15831274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonsurgical treatment of hepatocellular carcinoma.
    Llovet JM; Sala M; Bruix J
    Liver Transpl; 2000 Nov; 6(6 Suppl 2):S11-5. PubMed ID: 11084079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term results of chemoembolization of primary liver cancer with epirubicin-lipiodol].
    Pirschel J; Lauchart W
    Helv Chir Acta; 1993 Mar; 59(4):631-6. PubMed ID: 8386147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of hepatocellular carcinoma].
    Allgaier HP; Deibert P; Blum U; Spangenberg HC; Moser E; Blum HE
    Schweiz Med Wochenschr; 1996 Nov; 126(46):1984-94. PubMed ID: 8984607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
    J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions.
    Wakabayashi H; Ushiyama T; Ishimura K; Izuishi K; Karasawa Y; Masaki T; Watanabe S; Kuriyama S; Maeta H
    J Surg Oncol; 2003 Feb; 82(2):98-103. PubMed ID: 12561065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
    Fan J; Wu Z; Tang Z
    Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
    Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
    J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis.
    Livraghi T
    Hepatogastroenterology; 2001; 48(37):20-4. PubMed ID: 11268965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The present status of treatments for hepatocellular carcinoma.
    Tanikawa K
    Princess Takamatsu Symp; 1995; 25():245-52. PubMed ID: 8875630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Locoregional treatment of hepatocellular carcinoma: comparison between percutaneous alcohol administration and intraarterial chemoembolization].
    Cioni G; Turrini F; Pedrazzini PG; Cristani A; Ventura E; Ferrari A; D'Alimonte P; Ariosi P; De Santis M
    Recenti Prog Med; 2002 Jun; 93(6):361-6. PubMed ID: 12085715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effect of transcatheter arterial chemoembolization and percutaneous injection of acetic acids on primary liver cancer.
    Chen HB; Huang Y; Dai DL; Zhang X; Huang ZW; Zhang QK; Wang HH; Zhang JS; Pan G
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):55-7. PubMed ID: 14969838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation for malignancy.
    Hertl M; Cosimi AB
    Oncologist; 2005 Apr; 10(4):269-81. PubMed ID: 15821247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous microwave coagulation therapy for primary or recurrent hepatocellular carcinoma: long-term results.
    Itamoto T; Katayama K; Fukuda S; Fukuda T; Yano M; Nakahara H; Okamoto Y; Sugino K; Marubayashi S; Asahara T
    Hepatogastroenterology; 2001; 48(41):1401-5. PubMed ID: 11677974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.